learn Pyrilutamide
highly targeted anti-androgen that might have minimal systemic effects
Search
forProducts matching "kintor kx-826"
Tracking 2 products like 99 Pyrilutamide solution and 379 KX-826 DHT Blocker Hair Thickening,3 Days Oil Control from by companies like MinoxidilMax and Amazon. View all 2 products »Learn
1 / 1 resultsResearch
5 / 319 results
research Development and Validation of Androgen-Induced Hair Loss and Anagen Induction Mouse Models for Pharmacological Evaluation of Anti-Androgenic Agents
The mouse models are effective for testing new hair loss treatments.
research Topical Solutions for Androgenetic Alopecia: Evaluating Efficacy and Safety
Topical treatments for hair loss can be effective but need careful safety evaluation.
research Androgenetic Alopecia: Therapy Update
There are many treatments for common hair loss, but more trials are needed to decide which are best.
research What's New in Therapy for Male Androgenetic Alopecia?
research Serum Ferritin Levels in Non-Scarring Alopecia of Women: A Case-Control Study
Women with certain types of hair loss may have low iron levels, and iron supplements could help.
Community Join
5 / 318 resultscommunity Kintor KX -826 Pyrilutamide Adds 1 Year Phase 3 Trial For Safety
KX-826/pyrilutamide is undergoing an additional one-year safety and efficacy trial in China after a six-month study. Some participants speculate on the reasons for the extended trial and discuss the potential of other treatments.
community Kintor KX-826 Group Buy Feedback
The conversation is about a group of people trying KX-826 for hair loss, with no serious side effects reported after 25 days of use. Some participants are experiencing less scalp itch and shedding, but it's too early for definitive results.
community Received Kintor’s KX-826 Today
A user received Kintor’s KX-826/Pyrilutamide and shared initial impressions, noting concerns about the product's labeling and marketing. Other users discussed the legitimacy of the product, its effectiveness, and compared it to other treatments like Minoxidil and Finasteride.
community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025
Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.
community Kintor's KX-826 Phase 2 data release is officially pushed back to September due to COVID:
Hair loss discussion includes treatments Min, Fin, and RU. Kintor's KX-826 Phase 2 data release delayed to September due to COVID.